Publications by authors named "Charles B Chesson"

Claim this Profile
L
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
Amber Hickman, Joost Koetsier, Trevin Kurtanich, Michael C Nielsen, Glenn Winn, Charles B Chesson

J Clin Invest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.
Mark N Stein, Jyoti Malhotra, Rohinton S Tarapore, Usha Malhotra, Ann W Silk, Charles B Chesson

J Immunother Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis.
Charles B Chesson, Matthew Huante, Rebecca J Nusbaum, Aida G Walker, Tara M Clover

Sci Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
Jenna H Newman, David J Augeri, Rachel NeMoyer, Jyoti Malhotra, Elaine Langenfeld, Charles B Chesson

Oncogene· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
Jessica Wagner, C Leah Kline, Lanlan Zhou, Kerry S Campbell, Alexander W MacFarlane, Charles B Chesson

J Clin Invest· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.
Charles B Chesson, Andrew Zloza

Nanomedicine (Lond)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomaterials-Based Vaccination Strategies for the Induction of CD8T Cell Responses.
Charles B Chesson, Shaunte Ekpo-Otu, Janice J Endsley, Jai S Rudra

ACS Biomater Sci Eng· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.
Wei-Chun J Hsu, Federico Scala, Miroslav N Nenov, Norelle C Wildburger, Hannah Elferink, Charles B Chesson

FASEB J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of research and development of vaccines for chikungunya.
Claire Smalley, Jesse H Erasmus, Charles B Chesson, David W C Beasley

Vaccine· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide nanofiber-CaCO composite microparticles as adjuvant-free oral vaccine delivery vehicles.
Joshua D Snook, Charles B Chesson, Alex G Peniche, Sara M Dann, Adriana Paulucci

J Mater Chem B· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry.
Rajagopal Appavu, Charles B Chesson, Alexey Y Koyfman, Joshua D Snook, Frederick J Kohlhapp

ACS Biomater Sci Eng· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenic peptide nanofibers elicit adjuvant-free CD8⁺ T cell responses.
Charles B Chesson, Erica J Huelsmann, Andrew T Lacek, Frederick J Kohlhapp, Matthew F Webb

Vaccine· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis